Patents by Inventor Hans-Reiner Figulla
Hans-Reiner Figulla has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240016488Abstract: The present invention relates to an occlusion device (1) consisting of a braiding (2) of thin wires or threads (4) which is given a suitable form in a molding and heat treatment procedure. The occlusion device (1) has a proximal retention area (6) and a distal retention area (8), whereby the ends of the wires or threads (4) converge into a holder (5) in distal retention area (8). A cylindrical crosspiece (10) is furthermore disposed between the proximal and distal retention areas (6, 8). With the objective of providing an occlusion device which positions as flat as possible against the septum at the proximal side of a septal defect in the inserted state, the invention provides for the proximal retention area (6) of the braiding (2) to exhibit a completely closed proximal wall (112) disposed with a continuous surface at the proximal end of the occlusion device (1) which forms the proximal end (12) of said occlusion device (1).Type: ApplicationFiled: August 2, 2023Publication date: January 18, 2024Applicant: Occlutech GmbHInventors: Robert Moszner, Hans-Reiner Figulla, Friedrich Moszner, Florian Krizanic
-
Patent number: 11751858Abstract: The present invention relates to an occlusion device (1) consisting of a braiding (2) of thin wires or threads (4) which is given a suitable form in a molding and heat treatment procedure. The occlusion device (1) has a proximal retention area (6) and a distal retention area (8), whereby the ends of the wires or threads (4) converge into a holder (5) in distal retention area (8). A cylindrical crosspiece (10) is furthermore disposed between the proximal and distal retention areas (6, 8). With the objective of providing an occlusion device which positions as flat as possible against the septum at the proximal side of a septal defect in the inserted state, the invention provides for the proximal retention area (6) of the braiding (2) to exhibit a completely closed proximal wall (112) disposed with a continuous surface at the proximal end of the occlusion device (1) which forms the proximal end (12) of said occlusion device (1).Type: GrantFiled: January 16, 2020Date of Patent: September 12, 2023Assignee: Occlutech GmbHInventors: Robert Moszner, Hans-Reiner Figulla, Friedrich Moszner, Florian Krizanic
-
Publication number: 20230100094Abstract: The invention relates to a catheter for the transvascular implantation of prosthetic heart valves, in particular including self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve with anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which includes a flexible region (9) that can be guided through the aorta.Type: ApplicationFiled: December 5, 2022Publication date: March 30, 2023Applicant: JenaValve Technology, Inc.Inventors: Rudiger OTTMA, Robert MOSZNER, Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Patent number: 11517431Abstract: The invention relates to a catheter for the transvascular implantation of prosthetic heart valves, in particular including self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve with anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which includes a flexible region (9) that can be guided through the aorta.Type: GrantFiled: October 28, 2019Date of Patent: December 6, 2022Assignee: JenaValve Technology, Inc.Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Publication number: 20220304803Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it, is implanted.Type: ApplicationFiled: June 8, 2022Publication date: September 29, 2022Applicant: JenaValve Technology, Inc.Inventors: Volker GUYENOT, Thomas PESCHEL, Christoph DAMM, Hans-Reiner FIGULLA, Markus FERRARI, Johannes JUNG
-
Patent number: 11357624Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: GrantFiled: December 10, 2019Date of Patent: June 14, 2022Assignee: JenaValve Technology, Inc.Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
-
Publication number: 20210386541Abstract: The invention relates to an implant (1) for treating and/or for replacing a heart valve (100) diseased by an inflammation and/or infection, wherein the implant (1) has a catching device (2) which, in a compressed state, can be introduced in a minimally invasive manner into the body of the patient, and which can be expanded at the implantation site on the diseased heart valve (100), wherein the catching device (2) is designed, at least in the implanted and expanded state, to compartmentalise tissue changes or tissue deposits (101), in particular in the form of heart valve vegetation or deposits, in particular by using the catching device (2) to engage around and/or receive at least regions of the tissue change or deposit (101).Type: ApplicationFiled: April 5, 2019Publication date: December 16, 2021Inventors: Hans Reiner Figulla, Raphael A. Seidel
-
Patent number: 11116628Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: June 17, 2019Date of Patent: September 14, 2021Assignee: JenaValve Technology, Inc.Inventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Patent number: 10743852Abstract: The present invention relates to an occlusion device (1) consisting of a braiding (2) of thin wires or threads (4) which is given a suitable form in a molding and heat treatment procedure. The occlusion device (1) has a proximal retention area (6) and a distal retention area (8), whereby the ends of the wires or threads (4) converge into a holder (5) in distal retention area (8). A cylindrical crosspiece (10) is furthermore disposed between the proximal and distal retention areas (6, 8). With the objective of providing an occlusion device which positions as flat as possible against the septum at the proximal side of a septal defect in the inserted state, the invention provides for the proximal retention area (6) of the braiding (2) to exhibit a completely closed proximal wall (112) disposed with a continuous surface at the proximal end of the occlusion device (1) which forms the proximal end (12) of said occlusion device (1).Type: GrantFiled: November 21, 2016Date of Patent: August 18, 2020Assignee: Occlutech Holding AGInventors: Robert Moszner, Hans-Reiner Figulla, Friedrich Moszner, Florian Krizanic
-
Publication number: 20200222182Abstract: A method of treating or preventing endocarditis in a patient in need of therapy is disclosed. The method includes identifying a patient inflicted with or being at risk of contracting endocarditis caused by streptococci, staphylococci, or entercocci; and locally delivery in the vicinity of an aortic valve a therapeutically effective amount of an antibiotic or antimicrobial agent for the systemic delivery of the antibiotic or antimicrobial agent to the aortic valve for the treatment or prevention of endocarditis.Type: ApplicationFiled: March 26, 2020Publication date: July 16, 2020Inventors: ALEXANDER LAUTEN, HANS REINER FIGULLA
-
Publication number: 20200179110Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: ApplicationFiled: December 10, 2019Publication date: June 11, 2020Applicant: JenaValve Technology, Inc.Inventors: Volker GUYENOT, Thomas PESCHEL, Christoph DAMM, Hans-Reiner FIGULLA, Markus FERRARI, Johannes JUNG
-
Patent number: 10660749Abstract: The invention relates to a heart valve prosthesis for percutaneous replacement of a tricuspid valve including a stent-type support structure and a biological heart valve; the stent-type support structure can autonomously expand from a radially compressed state into a radially expanded state and includes a fluid-tight cover which extends like a tube over at least some portions of the support structure; the heart valve is arranged in a lateral opening in the support structure. Embodiments further relate to a system including a heart valve prosthesis of said type.Type: GrantFiled: January 17, 2017Date of Patent: May 26, 2020Assignee: NVT AGInventors: Hans Reiner Figulla, Alexander Lauten
-
Publication number: 20200146662Abstract: The present invention relates to an occlusion device (1) consisting of a braiding (2) of thin wires or threads (4) which is given a suitable form in a molding and heat treatment procedure. The occlusion device (1) has a proximal retention area (6) and a distal retention area (8), whereby the ends of the wires or threads (4) converge into a holder (5) in distal retention area (8). A cylindrical crosspiece (10) is furthermore disposed between the proximal and distal retention areas (6, 8). With the objective of providing an occlusion device which positions as flat as possible against the septum at the proximal side of a septal defect in the inserted state, the invention provides for the proximal retention area (6) of the braiding (2) to exhibit a completely closed proximal wall (112) disposed with a continuous surface at the proximal end of the occlusion device (1) which forms the proximal end (12) of said occlusion device (1).Type: ApplicationFiled: January 16, 2020Publication date: May 14, 2020Applicant: Occlutech Holding AGInventors: Robert Moszner, Hans-Reiner Figulla, Friedrich Moszner, Florian Krizanic
-
Publication number: 20200129290Abstract: The invention relates to a catheter for the transvascular implantation of prosthetic heart valves, in particular comprising self-expanding anchorage supports (10), which allow a minimally invasive implantation of prosthetic heart valves. The aim of the invention is to reduce the risk to the patient during the implantation. To achieve this, according to the invention a prosthetic heart valve comprising anchorage supports is temporarily housed in a folded form in a cartridge-type unit (4) during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system (1), which comprises a flexible region (9) that can be guided through the aorta.Type: ApplicationFiled: October 28, 2019Publication date: April 30, 2020Applicant: JENAVALVE TECHNOLOGY, INC.Inventors: Rüdiger OTTMA, Robert MOSZNER, Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Patent number: 10543084Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: GrantFiled: February 6, 2018Date of Patent: January 28, 2020Assignee: JenaValve Technology, Inc.Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
-
Publication number: 20190365532Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: ApplicationFiled: June 17, 2019Publication date: December 5, 2019Applicant: JenaValve Technology, Inc.Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM
-
Patent number: 10492906Abstract: A catheter is described for the transvascular implantation of prosthetic heart valves, e.g., including self-expanding anchorage supports, to reduce the risk to the patient during the implantation. Accordingly, a prosthetic heart valve with anchorage supports is temporarily housed in a folded form in a cartridge-type unit during the implantation. The cartridge-type unit can be fixed on the proximal end of a guide system, which includes a flexible region that can be guided through the aorta. Actuating elements run through the interior of the hollow guide system, permitting sections of the cartridge-type unit to be displaced radially about their longitudinal axis and/or laterally in a proximal direction, thus allowing individual sections of the anchorage support and the associated prosthetic heart valve to be sequentially released.Type: GrantFiled: September 11, 2017Date of Patent: December 3, 2019Assignee: JenaValve Technology, Inc.Inventors: Rüdiger Ottma, Robert Moszner, Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Patent number: 10363134Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: GrantFiled: November 22, 2017Date of Patent: July 30, 2019Assignee: JenaValve Technology, Inc.Inventors: Hans-Reiner Figulla, Markus Ferrari, Christoph Damm
-
Publication number: 20190008637Abstract: A medical device for treating a heart valve insufficiency, with an endoprosthesis which can be introduced into a patient's body and expanded to secure a heart valve prosthesis in the patient's aorta. In an embodiment, the endoprosthesis has a plurality of positioning arches configured to be positioned with respect to a patient's aorta and a plurality of retaining arches to support a heart valve prosthesis. The endoprosthesis includes a first collapsed mode during the process of introducing it into the patient's body and a second expanded mode when it is implanted.Type: ApplicationFiled: February 6, 2018Publication date: January 10, 2019Applicant: JenaValve Technology, Inc.Inventors: Volker Guyenot, Thomas Peschel, Christoph Damm, Hans-Reiner Figulla, Markus Ferrari, Johannes Jung
-
Publication number: 20180318072Abstract: A device for the transvascular implantation and fixation of prosthetic heart valves having a self-expanding heart valve stent (10) with a prosthetic heart valve (11) at its proximal end is introducible into a patient's main artery. With the objective of optimizing such a device to the extent that the prosthetic heart valve (11) can be implanted into a patient in a minimally-invasive procedure, to ensure optimal positioning accuracy of the prosthesis (11) in the patient's ventricle, the device includes a self-expanding positioning stent (20) introducible into an aortic valve positioned within a patient. The positioning stent is configured separately from the heart valve stent (10) so that the two stents respectively interact in their expanded states such that the heart valve stent (10) is held by the positioning stent (20) in a position in the patient's aorta relative the heart valve predefinable by the positioning stent (20).Type: ApplicationFiled: November 22, 2017Publication date: November 8, 2018Applicant: JenaValve Technology, Inc.Inventors: Hans-Reiner FIGULLA, Markus FERRARI, Christoph DAMM